npj Vaccines,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: April 19, 2021
Abstract
Emergency
use
authorization
of
COVID
vaccines
has
brought
hope
to
mitigate
pandemic
coronavirus
disease
2019
(COVID-19).
However,
there
remains
a
need
for
additional
effective
meet
the
global
demand
and
address
potential
new
viral
variants.
mRNA
technologies
offer
an
expeditious
path
alternative
traditional
vaccine
approaches.
Here
we
describe
efforts
utilize
platform
rational
design
evaluations
candidates
based
on
spike
(S)
glycoprotein
SARS-CoV-2.
Several
constructs
S-protein,
including
wild
type,
pre-fusion
stabilized
mutant
(2P),
furin
cleavage-site
(GSAS)
double
form
(2P/GSAS),
as
well
others,
were
tested
in
animal
models
their
capacity
elicit
neutralizing
antibodies
(nAbs).
The
lead
2P/GSAS
candidate
was
further
assessed
dose-ranging
studies
mice
Cynomolgus
macaques,
efficacy
Syrian
golden
hamster
model.
selected
formulation,
designated
MRT5500,
elicited
potent
nAbs
measured
neutralization
assays
all
three
preclinical
more
importantly,
protected
against
SARS-CoV-2-induced
weight
loss
lung
pathology
hamsters.
In
addition,
MRT5500
T
H
1-biased
responses
both
mouse
non-human
primate
(NHP),
thus
alleviating
hypothetical
concern
vaccine-associated
enhanced
respiratory
diseases
known
associated
with
2-biased
responses.
These
data
position
viable
entering
clinical
development.
Cell,
Journal Year:
2020,
Volume and Issue:
181(5), P. 1016 - 1035.e19
Published: April 27, 2020
There
is
pressing
urgency
to
understand
the
pathogenesis
of
severe
acute
respiratory
syndrome
coronavirus
clade
2
(SARS-CoV-2),
which
causes
disease
COVID-19.
SARS-CoV-2
spike
(S)
protein
binds
angiotensin-converting
enzyme
(ACE2),
and
in
concert
with
host
proteases,
principally
transmembrane
serine
protease
(TMPRSS2),
promotes
cellular
entry.
The
cell
subsets
targeted
by
tissues
factors
that
regulate
ACE2
expression
remain
unknown.
Here,
we
leverage
human,
non-human
primate,
mouse
single-cell
RNA-sequencing
(scRNA-seq)
datasets
across
health
uncover
putative
targets
among
tissue-resident
subsets.
We
identify
TMPRSS2
co-expressing
cells
within
lung
type
II
pneumocytes,
ileal
absorptive
enterocytes,
nasal
goblet
secretory
cells.
Strikingly,
discovered
a
human
interferon-stimulated
gene
(ISG)
vitro
using
airway
epithelial
extend
our
findings
vivo
viral
infections.
Our
data
suggest
could
exploit
species-specific
interferon-driven
upregulation
ACE2,
tissue-protective
mediator
during
injury,
enhance
infection.
Signal Transduction and Targeted Therapy,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: June 11, 2021
Abstract
The
pandemic
of
coronavirus
disease
2019
(COVID-19)
caused
by
severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection
has
resulted
in
an
unprecedented
setback
for
global
economy
and
health.
SARS-CoV-2
exceptionally
high
level
transmissibility
extremely
broad
tissue
tropism.
However,
the
underlying
molecular
mechanism
responsible
sustaining
this
degree
virulence
remains
largely
unexplored.
In
article,
we
review
current
knowledge
crucial
information
about
how
attaches
on
surface
host
cells
through
a
variety
receptors,
such
as
ACE2,
neuropilin-1,
AXL,
antibody–FcγR
complexes.
We
further
explain
its
spike
(S)
protein
undergoes
conformational
transition
from
prefusion
to
postfusion
with
help
proteases
like
furin,
TMPRSS2,
cathepsins.
then
ongoing
experimental
studies
clinical
trials
antibodies,
peptides,
or
small-molecule
compounds
anti-SARS-CoV-2
activity,
discuss
these
antiviral
therapies
targeting
host–pathogen
interaction
could
potentially
suppress
viral
attachment,
reduce
exposure
fusion
peptide
curtail
membrane
block
formation
six-helix
bundle
(6-HB)
core.
Finally,
specter
rapidly
emerging
variants
deserves
serious
broad-spectrum
drugs
vaccines
long-term
prevention
control
COVID-19
future.
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2020,
Volume and Issue:
39(8), P. 3025 - 3033
Published: April 10, 2020
The
widespread
antigenic
changes
lead
to
the
emergence
of
a
new
type
coronavirus
(CoV)
called
as
severe
acute
respiratory
syndrome
(SARS)-CoV-2
that
is
immunologically
different
from
previous
circulating
species.
Angiotensin-converting
enzyme-2
(ACE-2)
one
most
important
receptors
on
cell
membrane
host
cells
(HCs)
which
its
interaction
with
spike
protein
(SP)
furin-cleavage
site
results
in
SARS-CoV-2
invasion.
Hence,
this
review,
we
presented
an
overview
ACE-2
and
furin
SP.
As
several
kinds
CoVs,
various
genera,
have
at
their
S1/S2
binding
preserved
site,
further
surveyed
role
cleavage
(FCS)
life
cycle
CoV.
Furthermore,
discussed
small
molecular
inhibitors
can
limit
SP
be
used
potential
therapeutic
platforms
combat
spreading
CoV
epidemic.
Finally,
some
ongoing
challenges
future
prospects
for
development
drugs
promote
targeting
specific
activities
were
reviewed.
In
conclusion,
review
may
pave
way
providing
useful
information
about
compounds
involved
improving
effectiveness
vaccine
or
minimum
toxicity
against
human
health.Communicated
by
Ramaswamy
H.
Sarma.
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(10), P. 3544 - 3544
Published: May 17, 2020
The
current
Coronavirus
disease
2019
or
COVID-19
pandemic
has
infected
over
two
million
people
and
resulted
in
the
death
of
one
hundred
thousand
at
time
writing
this
review.
is
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
Even
though
multiple
vaccines
treatments
are
under
development
so
far,
only
slowing
down
extreme
social
distancing
measures
that
difficult
to
maintain.
SARS-COV-2
an
enveloped
virus
surrounded
a
lipid
bilayer.
Lipids
fundamental
cell
components
play
various
biological
roles
ranging
from
being
structural
building
block
signaling
molecule
as
well
central
energy
store.
role
lipids
viral
infection
involves
fusion
membrane
host
cell,
replication,
endocytosis
exocytosis.
Since
crucial
function
life
cycle,
we
asked
whether
drugs
targeting
metabolism,
such
statins,
can
be
utilized
against
SARS-CoV-2
other
viruses.
In
review,
discuss
metabolism
possibility
interfere
with
cycle.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2020,
Volume and Issue:
unknown
Published: April 20, 2020
ABSTRACT
The
COVID-19
pandemic,
caused
by
the
novel
coronavirus
SARS-CoV-2,
creates
an
urgent
need
for
identifying
molecular
mechanisms
that
mediate
viral
entry,
propagation,
and
tissue
pathology.
Cell
membrane
bound
angiotensin-converting
enzyme
2
(ACE2)
associated
proteases,
transmembrane
protease
serine
(TMPRSS2)
Cathepsin
L
(CTSL),
were
previously
identified
as
mediators
of
SARS-CoV2
cellular
entry.
Here,
we
assess
cell
type-specific
RNA
expression
ACE2
,
TMPRSS2
CTSL
through
integrated
analysis
107
single-cell
single-nucleus
RNA-Seq
studies,
including
22
lung
airways
datasets
(16
unpublished),
85
from
other
diverse
organs.
Joint
accessory
proteases
identifies
specific
subsets
respiratory
epithelial
cells
putative
targets
infection
in
nasal
passages,
airways,
alveoli.
Cells
co-express
are
also
organs,
some
which
have
been
with
transmission
or
pathology,
gut
enterocytes,
corneal
cells,
cardiomyocytes,
heart
pericytes,
olfactory
sustentacular
renal
cells.
Performing
first
meta-analyses
scRNA-seq
analyzed
1,176,683
282
nasal,
airway,
parenchyma
samples
164
donors
spanning
fetal,
childhood,
adult,
elderly
age
groups,
associate
increased
levels
types
increasing
age,
male
gender,
smoking,
all
epidemiologically
linked
to
susceptibility
outcomes.
Notably,
there
was
a
particularly
low
few
young
pediatric
analysis.
Further
reveals
gene
program
shared
+
tissues,
genes
may
subtend
key
immune
functions,
epithelial-macrophage
cross-talk.
Amongst
these
IL6,
its
receptor
co-receptor,
IL1R
TNF
response
pathways,
complement
genes.
type
specificity
smoking
effects
conserved
mice.
Our
analyses
suggest
differences
SARS-CoV-2
entry
be
responsible
aspects
epidemiology
clinical
course,
point
pathways
involved
disease
pathogenesis.
Cell Reports,
Journal Year:
2020,
Volume and Issue:
33(2), P. 108254 - 108254
Published: Sept. 23, 2020
Development
of
specific
antiviral
agents
is
an
urgent
unmet
need
for
SARS-coronavirus
2
(SARS-CoV-2)
infection.
This
study
focuses
on
host
proteases
that
proteolytically
activate
the
SARS-CoV-2
spike
protein,
critical
its
fusion
after
binding
to
angiotensin-converting
enzyme
(ACE2),
as
targets.
We
first
validate
cleavage
at
a
putative
furin
substrate
motif
spikes
by
expressing
it
in
VeroE6
cells
and
find
prominent
syncytium
formation.
Cleavage
are
abolished
treatment
with
inhibitors
decanoyl-RVKR-chloromethylketone
(CMK)
naphthofluorescein,
but
not
transmembrane
protease
serine
(TMPRSS2)
inhibitor
camostat.
CMK
naphthofluorescein
show
effects
SARS-CoV-2-infected
decreasing
virus
production
cytopathic
effects.
Further
analysis
reveals
that,
similar
camostat,
blocks
entry,
further
suppresses
syncytium.
Naphthofluorescein
acts
primarily
suppressing
viral
RNA
transcription.
Therefore,
may
be
promising
prevention
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2020,
Volume and Issue:
unknown
Published: Aug. 26, 2020
Abstract
SARS-CoV-2
has
resulted
in
a
global
pandemic
and
shutdown
economies
around
the
world.
Sequence
analysis
indicates
that
novel
coronavirus
(CoV)
an
insertion
of
furin
cleavage
site
(PRRAR)
its
spike
protein.
Absent
other
group
2B
CoVs,
may
be
key
factor
replication
virulence
SARS-CoV-2.
To
explore
this
question,
we
generated
mutant
lacking
(ΔPRRA)
This
virus
replicated
with
faster
kinetics
improved
fitness
Vero
E6
cells.
The
also
had
reduced
protein
processing
as
compared
to
wild-type
In
contrast,
ΔPRRA
Calu3
cells,
human
respiratory
cell
line,
attenuated
disease
hamster
pathogenesis
model.
Despite
disease,
offered
robust
protection
from
rechallenge.
Importantly,
plaque
reduction
neutralization
tests
(PRNT
50
)
COVID-19
patient
sera
monoclonal
antibodies
against
receptor-binding
domain
found
shift,
resulting
consistently
PRNT
titers.
Together,
these
results
demonstrate
critical
role
for
pathogenesis.
addition,
findings
illustrate
importance
evaluating
downstream
assays.
Importance
As
impacted
world,
understanding
how
replicates
causes
offers
potential
pathways
disrupt
disease.
By
removing
site,
cells
indicate
likelihood
culture
adaptations
stocks
can
influence
reagent
generation
interpretation
wide
range
data
including
drug
efficacy.
Overall,
our
work
highlights
motif
infection
Article
Summary
A
deletion
amplifies
but
attenuates
vivo.
Loss
reduces
susceptibility
vitro
.
Cells,
Journal Year:
2020,
Volume and Issue:
9(12), P. 2638 - 2638
Published: Dec. 8, 2020
The
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
has
recently
emerged
in
China
and
caused
a
disease
called
coronavirus
2019
(COVID-19).
virus
quickly
spread
around
the
world,
causing
sustained
global
outbreak.
Although
SARS-CoV-2,
other
coronaviruses,
SARS-CoV
Middle
East
CoV
(MERS-CoV)
are
highly
similar
genetically
at
protein
production
level,
there
significant
differences
between
them.
Research
shown
that
structural
spike
(S)
plays
an
important
role
evolution
transmission
of
SARS-CoV-2.
So
far,
studies
have
various
genes
encoding
primarily
for
elements
S
undergo
frequent
mutation.
We
performed
in-depth
review
literature
covering
mutational
aspects
context
compared
them
with
those
MERS-CoV.
Our
analytical
approach
consisted
initial
genome
transcriptome
analysis,
followed
by
primary,
secondary
tertiary
structure
analysis.
Additionally,
we
investigated
potential
effects
these
on
binding
interactions
to
angiotensin-converting
enzyme
2
(ACE2),
established,
after
extensive
analysis
previous
research
articles,
SARS-CoV-2
use
different
ends/regions
receptor-binding
motif
(RBM)
types
their
chief
ACE2.
These
may
implications
pathogenesis,
entry
ability
infect
intermediate
hosts
coronaviruses.
This
comprehensively
addresses
detail
variations
protein,
its
characteristics
detailed
interactions,
process
cleavage
involved
priming,
as
well